Table 2. Univariate and multivariate Cox regression analysis for overall survival.
| Characteristics |
Overall survival |
|||
|---|---|---|---|---|
|
Univariate |
Multivariate |
|||
| HR (95% CI) | P-valuea | HR (95% CI) | P-valuea | |
| Age (years): ≥60 versus <60 | 1.721 (0.918–3.230) | 0.091 | ||
| Gender: female versus male | 0.788 (0.428–1.451) | 0.788 | ||
| ECOG PS: ≥1 versus 0 | 1.960 (1.030–3.730) | 0.040 | 1.583 (0.811–3.088) | 0.178 |
| Tumor size (cm): >4 versus ≤4 | 2.557 (1.374–4.757) | 0.003 | 1.295 (0.633–2.652) | 0.479 |
| TNM stage: III+IV versus I+II | 6.480 (3.224–13.024) | <0.001 | 3.989 (1.299–12.253) | 0.016 |
| Tumor thrombus: yes versus no | 10.717 (3.867–29.706) | <0.001 | 3.042 (1.047–8.839) | 0.041 |
| Fuhrman grade: 3+4 versus 1+2 | 3.729 (1.931–7.202) | <0.001 | 1.018 (0.364–2.849) | 0.973 |
| Necrosis: present versus absent | 1.563 (0.863–2.830) | 0.140 | ||
| p-PAK1: high versus low | 3.627 (1.922–6.844) | <0.001 | 2.245 (1.085–4.645) | 0.029 |
Abbreviations: HR, hazard ratio; 95% CI, 95% confidence interval; ECOG-PS, Eastern Cooperative Oncology Group performance status; p-PAK1, phospho-p21-activated kinase 1
P<0.05 is considered statistically significant
Bold values indicate P<0.05